Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells
Chemotherapy is the standard of care for most malignancies. Its tumor debulking effect in adjuvant or neoadjuvant settings is unquestionable, although secondary effects have been reported that paradoxically promote metastasis. Chemotherapy affects the hematopoietic precursors leading to myelosuppres...
| Published in: | OncoImmunology |
|---|---|
| Main Authors: | Massimo Russo, Nicolò Panini, Paola Fabbrizio, Laura Formenti, Riccardo Becchetti, Cristina Matteo, Marina Meroni, Claudia Nastasi, Andrea Cappelleri, Roberta Frapolli, Giovanni Nardo, Eugenio Scanziani, Andrea Ponzetta, Maria Rosa Bani, Carmen Ghilardi, Raffaella Giavazzi |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2239035 |
Similar Items
Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal
by: Sapkota B, et al.
Published: (2020-05-01)
by: Sapkota B, et al.
Published: (2020-05-01)
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
by: Bernardo Leon Rapoport, et al.
Published: (2018-09-01)
by: Bernardo Leon Rapoport, et al.
Published: (2018-09-01)
Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2024-11-01)
by: Judith A. E. M. Zecha, et al.
Published: (2024-11-01)
Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment
by: Mayank Kapoor, et al.
Published: (2024-08-01)
by: Mayank Kapoor, et al.
Published: (2024-08-01)
Severe neutropenia caused by palliative radiation therapy in a case of metastatic hormone‐sensitive prostate cancer
by: Fumisato Maesaka, et al.
Published: (2024-11-01)
by: Fumisato Maesaka, et al.
Published: (2024-11-01)
Low dose pegylated recombinant human granulocyte colony-stimulating factor in the prophylactic treatment of grade Ⅲ/Ⅳ myelosuppression after chemotherapy
by: WANG Jin, TIE Xiaowei, FU Baobao, JIA Qianqian, WANG Fang, LI Wei
Published: (2024-10-01)
by: WANG Jin, TIE Xiaowei, FU Baobao, JIA Qianqian, WANG Fang, LI Wei
Published: (2024-10-01)
Clinical spectrum of pediatric neutropenia: mostly benign, but not to be overlooked
by: Şefika Akyol, et al.
Published: (2025-09-01)
by: Şefika Akyol, et al.
Published: (2025-09-01)
Chronic neutropenia in childhood: experience of a tertiary center
by: Letícia Matushita, et al.
Published: (2024-05-01)
by: Letícia Matushita, et al.
Published: (2024-05-01)
How I treat febrile neutropenia
by: Marcio Nucci
Published: (2021-02-01)
by: Marcio Nucci
Published: (2021-02-01)
La neutropenia
by: Efraín Pulla Cadmilema, et al.
Published: (2023-08-01)
by: Efraín Pulla Cadmilema, et al.
Published: (2023-08-01)
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
by: Maria Bachlitzanaki, et al.
Published: (2023-10-01)
by: Maria Bachlitzanaki, et al.
Published: (2023-10-01)
Terbinafine and Neutropenia
by: İrfan Yavasoğlu
Published: (2015-05-01)
by: İrfan Yavasoğlu
Published: (2015-05-01)
Effects of long-acting versus short-acting granulocyte colony stimulating factor after radiotherapy in gynecologic malignancies: a prospective observational cohort study
by: Xiaojing Chen, et al.
Published: (2024-12-01)
by: Xiaojing Chen, et al.
Published: (2024-12-01)
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by: Sang Ngoc Nguyen, et al.
Published: (2022-08-01)
by: Sang Ngoc Nguyen, et al.
Published: (2022-08-01)
Congenital Neutropenia in Children: Evaluation of Infectious Complications, Treatment Results and Long-Term Outcome
by: Işık Odaman Al, et al.
Published: (2021-08-01)
by: Işık Odaman Al, et al.
Published: (2021-08-01)
Neutropenia in pediatric hematology/oncology practice
by: E. A. Deordieva, et al.
Published: (2015-06-01)
by: E. A. Deordieva, et al.
Published: (2015-06-01)
Alloimmune Neutropenia in a Neonate: Case Report and Review of Literature
by: Arun Prasath, et al.
Published: (2022-10-01)
by: Arun Prasath, et al.
Published: (2022-10-01)
Secondary Neutropenias
by: Alister C. Ward
Published: (2025-02-01)
by: Alister C. Ward
Published: (2025-02-01)
Prevalencia de gérmenes con multirresistencia antibiótica en bacteriemia asociada a neutropenia febril en pacientes oncológicos hospitalizados
by: Carlos Soliz Poveda, et al.
Published: (2022-08-01)
by: Carlos Soliz Poveda, et al.
Published: (2022-08-01)
Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01)
by: I. B. Kononenko, et al.
Published: (2022-01-01)
Drug induced neutropenia manifesting as oral ulcerations
by: Rachna Kaul, et al.
Published: (2009-01-01)
by: Rachna Kaul, et al.
Published: (2009-01-01)
Mirtazapine-Induced Thrombocytopenia and Neutropenia
by: Selami K Toprak, et al.
Published: (2012-08-01)
by: Selami K Toprak, et al.
Published: (2012-08-01)
Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH
by: Marcio Nucci, et al.
Published: (2024-12-01)
by: Marcio Nucci, et al.
Published: (2024-12-01)
Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies
by: Ying Liu, et al.
Published: (2024-01-01)
by: Ying Liu, et al.
Published: (2024-01-01)
Different Pattern of Gene Mutations in Iranian Patients with Severe Congenital Neutropenia (Including 2 New Mutations)
by: Zahra Alizadeh, et al.
Published: (2013-03-01)
by: Zahra Alizadeh, et al.
Published: (2013-03-01)
Neutropenia in Childhood—A Narrative Review and Practical Diagnostic Approach
by: Georgios Katsaras, et al.
Published: (2024-06-01)
by: Georgios Katsaras, et al.
Published: (2024-06-01)
Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis—Induced Neutropenia
by: Pierpaolo Di Micco, et al.
Published: (2021-01-01)
by: Pierpaolo Di Micco, et al.
Published: (2021-01-01)
Neutropenia induced by ceftriaxone and meropenem
by: Zay Yar Aung, et al.
Published: (2024-05-01)
by: Zay Yar Aung, et al.
Published: (2024-05-01)
Febrile Neutropenia Due To Brucellosis: Case Report
by: Abdullah Sakin, et al.
Published: (2012-06-01)
by: Abdullah Sakin, et al.
Published: (2012-06-01)
Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
by: Mohsen Meidani, et al.
Published: (2018-01-01)
by: Mohsen Meidani, et al.
Published: (2018-01-01)
Severe neutropenia revealing a rare presentation of dengue fever: a case report
by: J. Shourick, et al.
Published: (2017-08-01)
by: J. Shourick, et al.
Published: (2017-08-01)
Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)
by: Kirti Malhotra, et al.
Published: (2015-06-01)
An update on the incidence, risk factors and mechanisms of rituximab-associated neutropenia
by: Xuehan Zhang, et al.
Published: (2022-09-01)
by: Xuehan Zhang, et al.
Published: (2022-09-01)
Neutropenia and Oral Infections in Children with Cancer
by: Şifa Şahin, et al.
Published: (2021-09-01)
by: Şifa Şahin, et al.
Published: (2021-09-01)
How to Make the Right Diagnosis in Neutropenia
by: Elena E. Solomou, et al.
Published: (2021-02-01)
by: Elena E. Solomou, et al.
Published: (2021-02-01)
Predictors of Chemotherapy Induced Neutropenia in Patients with Breast Cancer
by: Alper SARI, et al.
Published: (2025-08-01)
by: Alper SARI, et al.
Published: (2025-08-01)
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT
by: Ilaria Lazzareschi, et al.
Published: (2022-01-01)
by: Ilaria Lazzareschi, et al.
Published: (2022-01-01)
Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
by: Razan Zatarah, et al.
Published: (2022-10-01)
by: Razan Zatarah, et al.
Published: (2022-10-01)
Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)
by: G. D. Petrova, et al.
Published: (2015-12-01)
Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020-09-01)
by: O. D. Ostroumova, et al.
Published: (2020-09-01)
Similar Items
-
Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal
by: Sapkota B, et al.
Published: (2020-05-01) -
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
by: Bernardo Leon Rapoport, et al.
Published: (2018-09-01) -
Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2024-11-01) -
Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment
by: Mayank Kapoor, et al.
Published: (2024-08-01) -
Severe neutropenia caused by palliative radiation therapy in a case of metastatic hormone‐sensitive prostate cancer
by: Fumisato Maesaka, et al.
Published: (2024-11-01)
